PBE was created on 2005-06-23 by Invesco. The fund's investment portfolio concentrates primarily on health care equity. The ETF currently has 222.44m in AUM and 32 holdings. PBE tracks a tiered equal-weighted index of companies principally engaged in biotechnology and genetic engineering.
